BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27486757)

  • 1. The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population.
    Jiang C; Yu S; Qian P; Guo R; Zhang R; Ao Z; Li Q; Wu G; Chen Y; Li J; Wang C; Yao W; Xu J; Qian G; Ji F
    Oncotarget; 2016 Sep; 7(37):59742-59753. PubMed ID: 27486757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women.
    Ruiz-Narváez EA; Rosenberg L; Cozier YC; Cupples LA; Adams-Campbell LL; Palmer JR
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1320-7. PubMed ID: 20406955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China.
    He X; Yao G; Li F; Li M; Yang X
    Int J Mol Sci; 2014 Jan; 15(2):2130-41. PubMed ID: 24481062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reserch of the gene polymorphism TOX3 / LOC643714 and the risk of breast cancer development in persons exposed to ionizing radiation after Chornobyl disaster.
    Polinyk SI; Rybchenko LA; Klimyk BT
    Probl Radiac Med Radiobiol; 2017 Dec; 22():450-462. PubMed ID: 29286526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients.
    Gudmundsdottir ET; Barkardottir RB; Arason A; Gunnarsson H; Amundadottir LT; Agnarsson BA; Johannsson OT; Reynisdottir I
    BMC Cancer; 2012 Dec; 12():621. PubMed ID: 23270421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population.
    Tajbakhsh A; Javan FA; Rivandi M; Moezzi A; Abedini S; Asghari M; Farjami Z; Soltanian H; Shandiz FH; Kooshyar MM; Pasdar A
    Mol Biol Rep; 2019 Feb; 46(1):805-811. PubMed ID: 30515698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.
    Liang J; Chen P; Hu Z; Shen H; Wang F; Chen L; Li M; Tang J; Wang H; Shen H
    Breast Cancer Res Treat; 2010 Nov; 124(1):237-41. PubMed ID: 20213080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNRC9/LOC643714 polymorphisms are not associated with breast cancer risk in Chinese women.
    Li L; Zhou X; Huang Z; Liu Z; Song M; Guo Z
    Eur J Cancer Prev; 2009 Aug; 18(4):285-90. PubMed ID: 19398914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls.
    Zhang L; Long X
    Sci Rep; 2015 Aug; 5():12773. PubMed ID: 26239137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
    Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF;
    Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
    Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
    Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
    Chen Y; Shi C; Guo Q
    World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
    Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
    J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].
    Chen Q; He Y; Liu C; Liu H; Sun X; Shao Y; Huang T; Xu B
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2783-6. PubMed ID: 26711978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.
    Elematore I; Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G; Di Capua GA; Jara L
    Mol Biol Rep; 2014 Jun; 41(6):3715-22. PubMed ID: 24532140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the TOX3/LOC643714 and risk of breast cancer in south China.
    Liao J; Chen Y; Zhu J; Wang Q; Mo Z
    Int J Biol Markers; 2018 Apr; ():1724600818755633. PubMed ID: 29683073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of TOX3 in Chinese Han women with polycystic ovary syndrome.
    Cui Y; Zhao S; Zhao H; Lv Y; Yu M; Wang Y; Chen ZJ
    Reprod Biomed Online; 2014 Dec; 29(6):752-5. PubMed ID: 25311971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Association of
    Solis-Coronado O; Villarreal-Vela MP; Rodríguez-Gutiérrez HF; González-Guerrero JF; Cerda-Flores RM; Alcorta-Núñez F; Camarillo-Cárdenas KP; Pérez-Ibave DC; Vidal-Gutiérrez O; Ramírez-Correa GA; Garza-Rodríguez ML
    Curr Oncol; 2022 Feb; 29(2):1008-1017. PubMed ID: 35200585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs.
    Guan YP; Yang XX; Yao GY; Qiu F; Chen J; Chen LJ; Ye CS; Li M
    Asian Pac J Cancer Prev; 2014; 15(1):85-91. PubMed ID: 24528085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
    Palomba G; Loi A; Porcu E; Cossu A; Zara I; Budroni M; Dei M; Lai S; Mulas A; Olmeo N; Ionta MT; Atzori F; Cuccuru G; Pitzalis M; Zoledziewska M; Olla N; Lovicu M; Pisano M; Abecasis GR; Uda M; Tanda F; Michailidou K; Easton DF; Chanock SJ; Hoover RN; Hunter DJ; Schlessinger D; Sanna S; Crisponi L; Palmieri G
    BMC Cancer; 2015 May; 15():383. PubMed ID: 25956309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.